De Quervain tenosynovitis

De Quervain tenosynovitis is a stenosing tenosynovitis of the first dorsal compartment of the wrist, affecting the abductor pollicis longus (APL) and extensor pollicis brevis (EPB) tendons as they pass through a fibro-osseous tunnel at the radial styloid. Inflammation and thickening of the tendon sheath creates a mismatch between the sheath tunnel and the tendons, producing pain and crepitus with thumb and wrist movement. It is predominantly an overuse condition, most commonly affecting women aged 30–50 years and is strongly associated with activities requiring repetitive thumb abduction and radial deviation — including infant caregiving (new parent tenosynovitis), manual work, and certain sports. De Quervain tenosynovitis is highly responsive to corticosteroid injection, with success rates of 80–90% in most series.

De Quervain tenosynovitis results from stenosing inflammation of the fibro-osseous sheath of the first dorsal compartment. The pathology involves a combination of mechanical overuse and inflammatory changes within the tendon sheath, distinct from the purely degenerative angiofibroblastic process of epicondylar tendinopathy.

Anatomical and Pathological Basis

• First dorsal compartment anatomy — the fibro-osseous tunnel at the radial styloid contains the APL (abductor pollicis longus) and EPB (extensor pollicis brevis) tendons; the tunnel roof is a thickened retinaculum; the floor is the radial styloid; there is a fibrocartilaginous gliding surface within
• EPB subcompartment — in up to 34% of individuals, the EPB has a separate subcompartment within the first dorsal compartment; failure to inject into the EPB subcompartment is the most common cause of injection failure; ultrasound can identify this anatomical variant
• Stenosing inflammation — repetitive gliding of the APL and EPB causes synovial inflammation, oedema, and fibrous thickening of the tendon sheath; the sheath becomes narrowed relative to the tendon volume; mechanical friction during thumb and wrist movement produces pain and crepitus
• Association with postpartum period — new mothers are at high risk due to infant holding (wrist ulnar deviated with thumb abducted); hormonal changes in pregnancy (relaxin, oestrogen) may increase susceptibility to tenosynovitis; breastfeeding position is a specific aggravating factor

Risk Factors

• Female sex — approximately 8–10 times more common in women; hormonal influences and higher rates of infant caregiving
• Postpartum period — peak incidence in the first 6 months after delivery; baby-lifting and breastfeeding postures are the primary precipitants
• Repetitive radial deviation and thumb abduction — assembly line workers, musicians (particularly pianists and guitarists), gardeners, golfers
• Rheumatoid arthritis — inflammatory synovitis can involve the first dorsal compartment; bilateral De Quervain tenosynovitis should prompt screening for RA

De Quervain tenosynovitis presents with characteristic pain and tenderness over the radial styloid, provoked by thumb movements. The Finkelstein test is the most sensitive clinical examination finding. Diagnosis is clinical; imaging is used to confirm the diagnosis or exclude other pathology.

History

• Radial-sided wrist pain — pain at the radial aspect of the wrist and distal radius; may radiate proximally up the forearm and distally into the thumb; aggravated by thumb pinching, gripping, and wringing movements
• Activity-related onset — strongly associated with repetitive thumb and wrist activity; new parents typically note onset 1–4 weeks after returning to infant care; occupational precipitant in manual workers
• Swelling — visible or palpable swelling over the radial styloid is common; represents tenosynovial thickening; may be mistaken for a ganglion
• Bilateral involvement — bilateral De Quervain tenosynovitis in a postpartum woman is common and not worrying; bilateral disease in a non-postpartum context should prompt screening for RA and thyroid disease

Examination Findings

• Finkelstein's test — patient places the thumb in the palm with the fingers closed over it (making a fist); examiner passively ulnar deviates the wrist; pain reproduced at the radial styloid; the most sensitive test (sensitivity ~90%); note: Eichhoff test (same manoeuvre but examiner also pulls thumb) is commonly misnamed as Finkelstein's
• Point tenderness at radial styloid — exquisite tenderness directly over the first dorsal compartment at the radial styloid tip; the single most specific finding; tenderness should be localised to this point, not diffuse
• Crepitus — palpable or audible crepitus over the first dorsal compartment during thumb and wrist movement in some patients; indicates significant tenosynovial thickening
• Preserved wrist and thumb range of motion — active range of motion is preserved (painful at extremes); significant restriction suggests alternative diagnosis (scaphoid pathology, CMC OA, inflammatory arthritis)

De Quervain tenosynovitis is a clinical diagnosis. Investigations are used to exclude other wrist pathology and to confirm diagnosis and guide injection in atypical presentations or injection-refractory cases.

• Essential
  X-ray wrist (PA and lateral)

  Mandatory at first presentation to exclude scaphoid fracture, radial styloid fracture, CMC OA, and wrist OA. De Quervain tenosynovitis: X-ray usually normal. Scaphoid fracture may require CT or MRI if initial X-ray negative and clinical suspicion remains. CMC OA: joint space narrowing at the thumb CMC joint on PA view with stress.
• Recommended
  Musculoskeletal ultrasound

  Confirms De Quervain tenosynovitis (tenosynovial thickening, fluid in tendon sheath, Doppler vascularity). Identifies EPB subcompartment — present in 34% of cases; failure to inject into EPB subcompartment is the most common cause of injection failure. Guides corticosteroid injection into the correct compartment. Excludes partial tendon tear. Recommended before all injections in refractory cases.
• Specialised
  MRI wrist

  For atypical presentations, suspected scaphoid fracture (negative X-ray but persistent snuffbox tenderness), or to assess for concurrent ligamentous injury. Not required for typical De Quervain tenosynovitis. MRI shows tenosynovial signal abnormality and tendon sheath fluid in De Quervain; but ultrasound is preferred for this indication.
• Specialised
  RF, anti-CCP, ESR, CRP

  Indicated for bilateral De Quervain tenosynovitis without clear precipitant, to exclude rheumatoid arthritis. Also indicated if other joint involvement, prolonged morning stiffness, or systemic features are present.

Severity in De Quervain tenosynovitis guides the sequence of management: mild cases may respond to splinting and activity modification; moderate-severe cases should receive corticosteroid injection as first-line definitive treatment.

Corticosteroid injection into the first dorsal compartment is the most effective treatment for De Quervain tenosynovitis, with response rates of 80–90%. Topical and oral NSAIDs provide symptomatic analgesia. Ultrasound guidance improves injection success rates.

Splinting, activity modification, and surgical release are the non-pharmacological directed therapies for De Quervain tenosynovitis. Surgery is reserved for injection-refractory cases.

Thumb Spica Splint

• Design — splint immobilises the thumb (IP joint free) and wrist in slight radial deviation and extension; the first dorsal compartment tendons are placed in a position of relative rest; custom thermoplastic or prefabricated short thumb opponens splint
• Evidence — splinting alone has modest efficacy (50–60% improvement vs 80–90% with injection); most useful as adjunct post-injection or for patients who decline injection; worn during provocative activities, particularly infant care and work tasks
• Duration — typically worn for 4–6 weeks; may be continued until tenosynovitis fully resolves; full-time wearing provides more benefit than part-time; night splinting less critical for De Quervain tenosynovitis than for carpal tunnel syndrome

Activity Modification

• Infant care modification — for postpartum patients, teach correct lifting technique (scoop under the infant with wrists in neutral rather than ulnar deviation); use a firm feeding pillow to reduce wrist loading during breastfeeding; partner involvement in infant care during treatment
• Occupational modification — reduce repetitive thumb pinch and radial deviation tasks; ergonomic tool handles; job rotation; consider WorkCover if occupationally related and not resolving

Surgical Management

• First dorsal compartment release — surgical incision over the first dorsal compartment; release of the retinacular sheath; subcompartment septum divided if EPB has separate tunnel; performed under local anaesthesia as day procedure by hand surgeon; very high success rate (95%+) for injection-refractory cases
• Indications — failure of 2 corticosteroid injections (with ultrasound guidance ensuring EPB subcompartment targeted); duration >6 months; significant occupational or caregiving limitation; refer hand surgery if injection has failed twice
• Recovery — 2–3 weeks off work for manual workers; immediate use of the hand for light activities; physiotherapy post-operatively for scar management and range of motion

Non-pharmacological management forms the foundation of De Quervain tenosynovitis care — splinting reduces mechanical load on the inflamed sheath, activity modification removes the precipitant, and patient education enables appropriate self-management including correct infant lifting technique for postpartum patients.

Patient Education

• Postpartum-specific education — explain the association with infant care and hormonal changes; reassure that the condition typically resolves with treatment; provide written instructions on correct infant lifting technique (scoop hold, neutral wrist); involve partner or support person in infant care burden sharing during recovery
• Expected course — with corticosteroid injection, 80–90% resolve within 6–8 weeks; without injection, the natural course is 6–18 months; persistent symptoms beyond 2 injections warrant surgical referral
• Splint compliance — consistent splint use between consultations substantially improves outcomes; written instructions on correct application; night-time splinting optional but beneficial in severe cases

Physiotherapy

• Gentle tendon gliding exercises — post-injection and in the recovery phase; APL and EPB tendon gliding exercises maintain sheath mobility without overstressing the healing tendon; performed 2–3 times daily
• Progressive return to activity — structured activity progression from light pinch to full load over 4–8 weeks; physiotherapy involvement is most helpful in occupational cases where return-to-work functional assessment is required

Monitoring in De Quervain tenosynovitis focuses on pain response to injection, functional recovery, and identification of injection failure — particularly due to the EPB subcompartment.

Indications for Specialist Referral

• Failure of 2 corticosteroid injections (with ultrasound guidance on the second) — hand surgery referral for first dorsal compartment release
• Bilateral atypical presentation without postpartum context — rheumatology referral to exclude RA and inflammatory arthritis
• Suspected concurrent scaphoid fracture (anatomical snuffbox tenderness, negative X-ray) — urgent orthopaedic or hand surgery referral for CT or MRI

Specific clinical considerations apply to postpartum patients and other groups with De Quervain tenosynovitis.

Postpartum and Breastfeeding Patients

• Corticosteroid injection safety — triamcinolone injection in breastfeeding: small amount excreted in breast milk; risk considered minimal; advise patient to discard breast milk for 24 hours post-injection if concerned; benefits of treatment outweigh theoretical risk in most cases; consult with obstetric or breastfeeding medicine if significant concern
• NSAID safety — ibuprofen is preferred NSAID in breastfeeding (low transfer to milk); naproxen has higher milk transfer and should be avoided; all NSAIDs avoid in pregnancy beyond 20 weeks (premature ductus arteriosus closure)
• Splinting during infant care — thumb spica splint should be worn during all infant lifting and feeding; partner education about safe infant transfer while mother wears splint; hospital-grade support bra and breastfeeding pillow reduce wrist load
• Prognosis — postpartum De Quervain tenosynovitis typically resolves after cessation of breastfeeding and infant lifting demands reduce; most resolve within 6–12 months postpartum with appropriate management

Workers with Occupational De Quervain Tenosynovitis

• WorkCover liaison — occupational De Quervain tenosynovitis is a compensable workplace injury; early WorkCover notification prevents prolonged absence; modified duties (reduced pinch grip and radial deviation) should be arranged promptly
• Return-to-work planning — most workers can return to modified duties within 1–2 weeks of injection; full duties within 4–6 weeks; occupational therapist functional capacity assessment for manual workers

Stewardship in De Quervain tenosynovitis centres on correct injection technique (sheath not tendon, targeting EPB subcompartment), avoiding repeated failed injections without investigating subcompartment anatomy, and appropriate use of NSAIDs in postpartum patients.

GP Role

• Confident clinical diagnosis — Finkelstein's test and point tenderness at the radial styloid are sufficient for diagnosis in most cases; X-ray to exclude fracture; proceed to treatment without ultrasound in typical presentations
• Injection as first-line definitive treatment — corticosteroid injection is the most effective treatment; do not delay injection beyond 4–6 weeks in moderate-severe cases; splinting alone is insufficient for most patients
• Ultrasound guidance for second injection — if first injection fails, arrange ultrasound-guided injection specifically targeting the EPB subcompartment; do not perform a third landmark-guided injection
• Hand surgery referral threshold — refer after 2 injections (with ultrasound guidance on the second) without response

With corticosteroid injection, most De Quervain tenosynovitis resolves within 6–8 weeks. Prevention focuses on ergonomic technique for infant care and activity modification to reduce recurrence.

Prevention

• Correct infant lifting technique — use a scoop hold under the infant with wrists in neutral; avoid pinch grip with thumb abducted; use a supportive nursing pillow to reduce wrist load during feeding
• Occupational ergonomics — reduce repetitive thumb pinch and radial deviation; ergonomic tool handles; job rotation to distribute forearm load
• Recurrence — De Quervain tenosynovitis can recur if precipitating activities resume before complete resolution; maintain splinting during high-risk activities for 4–6 weeks after symptom resolution

• 01
  Ilyas AM, et al. De Quervain tenosynovitis of the wrist. J Am Acad Orthop Surg. 2007;15(12):757–764.
• 02
  Avci S, Yilmaz C, Sayli U. Comparison of nonsurgical treatment measures for de Quervain's disease of pregnancy and lactation. J Hand Surg Am. 2002;27(2):322–324.
• 03
  Zingas C, et al. Failure of needle penetration in de Quervain's injections. J Hand Surg Am. 1998;23(6):1057–1059.
• 04
  Therapeutic Guidelines. Rheumatology. Melbourne: Therapeutic Guidelines Ltd; 2024.
• 05
  Pharmaceutical Benefits Scheme (PBS). Schedule of Pharmaceutical Benefits. Canberra: Department of Health; 2025.